Establishment of polycystic ovary syndrome-derived human embryonic stem cell lines. 2012

Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
Reproductive Medical Center, Department of Obstetrics and Gynecology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, China.

BACKGROUND Recently, human embryonic stem cells (hESCs) of some genetic diseases have been established, but little research has been done on polycystic ovary syndrome (PCOS)-derived hESCs. The establishment of PCOS-derived hESCs provides a biological basis for exploring the pathogenesis, gene mapping and gene therapy of PCOS. METHODS Discarded fresh embryos were collected and cultured until the blastocyst stage, and then inner cell masses (ICM) were isolated by mechanical methods and incubated in the mixed feeder layer containing human stem cell medium. hESCs were identified whether to maintain normal karyotype and pluripotency by alkaline phosphates (AKP), stage-specific embryonic antigen-4 (SSEA-4), NANOG, SOX2 and TRA-1-60, octamer binding protein 4(OCT-4), and in vivo and in vitro differentiation. RESULTS Of the 11 passaged ICM, nine showed adherent growths within 48 h with an adherence rate of 81.8% (9/11). Five PCOS-derived hESCs were established and all of them have the characteristics of pluripotent differentiation. One was from 2PN embryo which was retarded in the cleavage stage, one was from 1PN embryo and others were from 0PN embryo. They were named p-hES-1, p-hES-2, p-hES-3, p-hES-4, p-hES-5, respectively. CONCLUSIONS We provide biological models for studying the pathogenesiss of PCOS.

UI MeSH Term Description Entries
D008297 Male Males
D011085 Polycystic Ovary Syndrome A complex disorder characterized by infertility, HIRSUTISM; OBESITY; and various menstrual disturbances such as OLIGOMENORRHEA; AMENORRHEA; ANOVULATION. Polycystic ovary syndrome is usually associated with bilateral enlarged ovaries studded with atretic follicles, not with cysts. The term, polycystic ovary, is misleading. Stein-Leventhal Syndrome,Polycystic Ovarian Syndrome,Polycystic Ovary Syndrome 1,Sclerocystic Ovarian Degeneration,Sclerocystic Ovaries,Sclerocystic Ovary Syndrome,Ovarian Degeneration, Sclerocystic,Ovarian Syndrome, Polycystic,Ovary Syndrome, Polycystic,Ovary, Sclerocystic,Sclerocystic Ovary,Stein Leventhal Syndrome,Syndrome, Polycystic Ovary,Syndrome, Stein-Leventhal
D001755 Blastocyst A post-MORULA preimplantation mammalian embryo that develops from a 32-cell stage into a fluid-filled hollow ball of over a hundred cells. A blastocyst has two distinctive tissues. The outer layer of trophoblasts gives rise to extra-embryonic tissues. The inner cell mass gives rise to the embryonic disc and eventual embryo proper. Embryo, Preimplantation,Blastocysts,Embryos, Preimplantation,Preimplantation Embryo,Preimplantation Embryos
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D002469 Cell Separation Techniques for separating distinct populations of cells. Cell Isolation,Cell Segregation,Isolation, Cell,Cell Isolations,Cell Segregations,Cell Separations,Isolations, Cell,Segregation, Cell,Segregations, Cell,Separation, Cell,Separations, Cell
D004622 Embryo, Mammalian The entity of a developing mammal (MAMMALS), generally from the cleavage of a ZYGOTE to the end of embryonic differentiation of basic structures. For the human embryo, this represents the first two months of intrauterine development preceding the stages of the FETUS. Embryonic Structures, Mammalian,Mammalian Embryo,Mammalian Embryo Structures,Mammalian Embryonic Structures,Embryo Structure, Mammalian,Embryo Structures, Mammalian,Embryonic Structure, Mammalian,Embryos, Mammalian,Mammalian Embryo Structure,Mammalian Embryonic Structure,Mammalian Embryos,Structure, Mammalian Embryo,Structure, Mammalian Embryonic,Structures, Mammalian Embryo,Structures, Mammalian Embryonic
D005260 Female Females
D005307 Fertilization in Vitro An assisted reproductive technique that includes the direct handling and manipulation of oocytes and sperm to achieve fertilization in vitro. Test-Tube Fertilization,Fertilizations in Vitro,In Vitro Fertilization,Test-Tube Babies,Babies, Test-Tube,Baby, Test-Tube,Fertilization, Test-Tube,Fertilizations, Test-Tube,In Vitro Fertilizations,Test Tube Babies,Test Tube Fertilization,Test-Tube Baby,Test-Tube Fertilizations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015415 Biomarkers Measurable and quantifiable biological parameters (e.g., specific enzyme concentration, specific hormone concentration, specific gene phenotype distribution in a population, presence of biological substances) which serve as indices for health- and physiology-related assessments, such as disease risk, psychiatric disorders, ENVIRONMENTAL EXPOSURE and its effects, disease diagnosis; METABOLIC PROCESSES; SUBSTANCE ABUSE; PREGNANCY; cell line development; EPIDEMIOLOGIC STUDIES; etc. Biochemical Markers,Biological Markers,Biomarker,Clinical Markers,Immunologic Markers,Laboratory Markers,Markers, Biochemical,Markers, Biological,Markers, Clinical,Markers, Immunologic,Markers, Laboratory,Markers, Serum,Markers, Surrogate,Markers, Viral,Serum Markers,Surrogate Markers,Viral Markers,Biochemical Marker,Biologic Marker,Biologic Markers,Clinical Marker,Immune Marker,Immune Markers,Immunologic Marker,Laboratory Marker,Marker, Biochemical,Marker, Biological,Marker, Clinical,Marker, Immunologic,Marker, Laboratory,Marker, Serum,Marker, Surrogate,Serum Marker,Surrogate End Point,Surrogate End Points,Surrogate Endpoint,Surrogate Endpoints,Surrogate Marker,Viral Marker,Biological Marker,End Point, Surrogate,End Points, Surrogate,Endpoint, Surrogate,Endpoints, Surrogate,Marker, Biologic,Marker, Immune,Marker, Viral,Markers, Biologic,Markers, Immune

Related Publications

Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
February 2021, Immunology letters,
Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
May 2016, In vitro cellular & developmental biology. Animal,
Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
June 2016, Cell proliferation,
Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
May 2006, Human cell,
Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
May 2005, Reproductive biomedicine online,
Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
August 2005, Zhonghua fu chan ke za zhi,
Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
November 1998, Science (New York, N.Y.),
Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
March 2004, Rinsho byori. The Japanese journal of clinical pathology,
Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
April 2010, In vitro cellular & developmental biology. Animal,
Peng-fen Li, and Fang Wang, and Hui-juan Kong, and Fang Zhao, and Ai-hong Bai, and Xue-mei Chen, and Ying-pu Sun
April 2010, In vitro cellular & developmental biology. Animal,
Copied contents to your clipboard!